Orphazyme A/S (OZYMF)
USD 90.0
(0.0%)
USD 90.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -20.02 Thousand | -104.51 Million | -92.09 Million | -88.61 Million | -49.09 Million | -234.76 Million |
| Net Income | -26.04 Thousand | -38.3 Million | -11.99 Million | -104.09 Million | -50.69 Million | -229.6 Million |
| Depreciation & Amortization | - | 782 Thousand | -2.76 Million | -854.6 Thousand | -571.42 Thousand | 1.36 Million |
| Deferred income taxes | - | - | -4.94 Million | -1.91 Million | -5.5 Million | -5.5 Million |
| Stock-based compensation | 126.00 | 1773.00 | 16.01 Million | 28.1 Million | 2.54 Million | 2.1 Million |
| Change in working capital | 10.65 Thousand | -3.17 Million | -142.44 Thousand | 7.02 Million | 311.85 Thousand | -8.63 Million |
| Other non-cash items | -4750.00 | -55.57 Million | -88.26 Million | -16.88 Million | 4.81 Million | 17.5 Million |
| Investing Cash Flow | -6944.00 | 90.34 Million | 7030.46 | -838.49 Thousand | -493.46 Thousand | -2.34 Million |
| Investments in PPE | - | - | -151.91 Thousand | -838.49 Thousand | -493.46 Thousand | -2.34 Million |
| Acquisitions | - | 1.46 Million | 158.94 Thousand | - | - | - |
| Investment purchases | -6.94 Million | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -6944.00 | 88.88 Million | 0.44 | -449.08 | -76.26 | -245.97 |
| Financing Cash Flow | -685.00 | -35.07 Million | -4.63 Million | 190.58 Million | 8.85 Million | - |
| Debt repayment | - | -39.15 Million | -3.92 Million | -1.73 Million | -9.42 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -3020.00 | - | - | - | - | - |
| Common Stock Issuance | 2.33 Million | 5.31 Million | 70.91 Thousand | 192.8 Million | 2854.14 | - |
| Other Financing Activities | 2335.00 | 5310.00 | -251.87 Thousand | -107.85 Million | -3.83 Million | - |
| Accounts receivables | 4.18 Million | 1.11 Million | 431.91 Thousand | -5.53 Million | 739.07 Thousand | -14.57 Million |
| Accounts payables | -657 Thousand | -7.79 Million | -574.35 Thousand | 12.56 Million | -427.21 Thousand | 1.9 Million |
| Inventory | - | 0.50 | 0.54 | -0.15 | 0.47 | - |
| Other working capital | 10.65 Thousand | 3.5 Million | - | - | - | 4.03 Million |
| Cash at beginning of period | 38.91 Thousand | 102.25 Million | 726.92 Million | 123.58 Million | 394.7 Million | 631.73 Million |
| Cash at end of period | 11.26 Thousand | 38.91 Million | 102.25 Million | 726.92 Million | 123.58 Million | 394.7 Million |
| Capital Expenditure | - | - | -151.91 Thousand | -838.49 Thousand | -493.46 Thousand | -2.34 Million |
| Effect of forex changes on cash | 1.00 | 523.00 | 8.19 Million | -11.9 Million | 46 Thousand | 81 Thousand |
| Net cash flow / Change in cash | -27.64 Thousand | -63.33 Million | -624.67 Million | 603.34 Million | -271.11 Million | -237.02 Million |
| Free Cash Flow | -20.02 Thousand | -104.51 Million | -92.24 Million | -89.45 Million | -49.58 Million | -237.11 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.96 Million | -26.04 Million | -1.86 Million | -38.3 Million | -1.98 Million | -3.43 Million |
| Depreciation & Amortization | - | - | - | 782 Thousand | 261.16 Thousand | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | 126.00 | - | 1773.00 | - | - |
| Change in working capital | 210.34 Thousand | 527 Thousand | -130.61 Thousand | -3.17 Million | 11.83 Million | -12.5 Million |
| Other non-cash items | -70.16 Thousand | 1.97 Million | 357.65 Thousand | -55.57 Million | -36.34 Million | 26.49 Million |
| Investing Cash Flow | -1.02 Million | -6.94 Million | - | 90.34 Million | 12.75 Million | 205.13 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | 1.46 Million | 209.5 Thousand | - |
| Investment purchases | -1.02 Million | -6.94 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -6944.00 | - | 88.88 Million | 12.54 Million | 205.13 Thousand |
| Financing Cash Flow | -101.39 Thousand | -685 Thousand | - | -35.07 Million | - | -4.92 Million |
| Debt repayment | - | - | - | -39.15 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -447.02 Thousand | -3.02 Million | - | - | - | - |
| Common Stock Issuance | 345.63 Thousand | 2.33 Million | - | 5.31 Million | - | 746.05 Thousand |
| Other Financing Activities | - | 2335.00 | - | 5310.00 | 5.79 Million | -5.67 Million |
| Accounts receivables | -576.54 Thousand | 4.18 Million | 1.18 Million | 1.11 Million | 3.27 Million | 2.7 Million |
| Accounts payables | 1.23 Million | -657 Thousand | -1.31 Million | -7.79 Million | 8.55 Million | -15.21 Million |
| Inventory | -2.00 | - | - | 0.50 | - | - |
| Other working capital | -443.92 Thousand | -2.99 Million | 1.00 | 3.5 Million | - | 1.00 |
| Cash at beginning of period | 4.43 Million | 38.91 Million | 6.09 Million | 102.25 Million | 6.95 Million | 15.62 Million |
| Cash at end of period | 1.66 Million | 11.26 Million | 4.43 Million | 38.91 Million | 6.09 Million | 6.95 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -466.4 Thousand | 1.00 | - | 523.00 | - | -0.50 |
| Net cash flow / Change in cash | -2.76 Million | -27.64 Million | -1.66 Million | -63.33 Million | -865.66 Thousand | -8.66 Million |
| Free Cash Flow | -1.16 Million | -20.02 Million | -1.77 Million | -104.51 Million | -14.92 Million | -1.96 Million |
002879
2296
EQTL3
ODPV3
PWI
5916